Tekla Healthcare Investors/HQH

$15.95

-1.78%
-
1D1W1MYTD1YMAX

About Tekla Healthcare Investors

abrdn Healthcare Investors (the Fund), formerly Tekla Healthcare Investors, is a non-diversified closed-end healthcare fund. The Fund's investment objective is to seek long-term capital appreciation by investing primarily in securities of healthcare companies. In addition, it seeks to provide regular distribution of realized capital gains. It may invest up to 20% of its net assets in securities of foreign issuers, located primarily in Western Europe, Canada and Japan, and securities of United States issuers that are traded in foreign markets. It invests in healthcare industries and is focused on the smaller, emerging companies, investing a maximum of 40% of the Fund's assets in restricted securities of both public and private companies. It invests in subsectors, such as biotechnology, pharmaceuticals, healthcare equipment, healthcare supplies, life science tools and services, healthcare distributors, managed healthcare and others. abrdn Inc. is the investment adviser of the Fund.

Ticker

HQH

Sector

Financials

Trading on

NYSE

Industry

Misc. Financial Services

CEO

Employees

-

Headquarters

Philadelphia, United States

HQH Metrics

BasicAdvanced
$771.2M
Market cap
13.41
P/E ratio
$1.19
EPS
0.74
Beta
$0.82
Dividend rate
10.41%
Dividend yield
$771.2M
0.74391
$17.90
$14.31
154.42K
$0.82
137.44%
6.06%
6.1%
6.1%
13.414
74.933
0.847
0.828
5.14%
10.41%
24.44%
128.86%
4.83%
-40.82%

HQH Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-582.6% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$4.6M
-17.86%
Net income
$-26.8M
-132.25%
Profit margin
-582.6%
-139.26%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Tekla Healthcare Investors stock?

Tekla Healthcare Investors (HQH) has a market cap of $771.2M as of April 15, 2024.

What is the P/E ratio for Tekla Healthcare Investors stock?

The price to earnings (P/E) ratio for Tekla Healthcare Investors (HQH) stock is 13.41 as of April 15, 2024.

Does Tekla Healthcare Investors stock pay dividends?

Yes, the Tekla Healthcare Investors (HQH) stock pays dividends to shareholders. As of April 15, 2024, the dividend rate is $0.82 and the yield is 10.41%. Tekla Healthcare Investors has a payout ratio of 137.44% on a trailing twelve-month basis.

When is the next Tekla Healthcare Investors dividend payment date?

The next Tekla Healthcare Investors (HQH) dividend payment date is unconfirmed.

What is the beta indicator for Tekla Healthcare Investors?

Tekla Healthcare Investors (HQH) has a beta rating of 0.74. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Tekla Healthcare Investors stock price target?

The target price for Tekla Healthcare Investors (HQH) stock is $, which is 100% below the current price of $15.95. This is an average based on projections from analyst, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Tekla Healthcare Investors stock

Buy or sell Tekla Healthcare Investors stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing